Company registration number 11630382 (England and Wales)
THE CLINIC (AYCLIFFE) LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
PAGES FOR FILING WITH REGISTRAR
THE CLINIC (AYCLIFFE) LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
THE CLINIC (AYCLIFFE) LTD
BALANCE SHEET
AS AT 31 JULY 2025
31 July 2025
- 1 -
2025
2024
as restated
Notes
£
£
£
£
Fixed assets
Tangible assets
3
19,855
25,008
Investments
4
139,358
19,855
164,366
Current assets
Stocks
2,500
2,500
Debtors
5
205,657
29,782
Cash at bank and in hand
23,691
26,427
231,848
58,709
Creditors: amounts falling due within one year
6
(253,283)
(217,284)
Net current liabilities
(21,435)
(158,575)
Total assets less current liabilities
(1,580)
5,791
Creditors: amounts falling due after more than one year
7
(5,718)
Net (liabilities)/assets
(1,580)
73
Capital and reserves
Called up share capital
8
2
2
Revaluation reserve
77,280
Profit and loss reserves
(1,582)
(77,209)
Total equity
(1,580)
73
THE CLINIC (AYCLIFFE) LTD
BALANCE SHEET (CONTINUED)
AS AT 31 JULY 2025
31 July 2025
- 2 -
For the financial year ended 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 29 May 2026 and are signed on its behalf by:
R J Stainsby
Director
Company registration number 11630382 (England and Wales)
THE CLINIC (AYCLIFFE) LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
- 3 -
1
Accounting policies
Company information
The Clinic (Aycliffe) Ltd is a private company limited by shares incorporated in England and Wales. The registered office is The Oak Centre, Whinfield Drive, Aycliffe Business Park, Newton Aycliffe, County Durham, DL5 6AU.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of intangible assets. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Revenue
Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Leasehold improvements
Straight line basis over term of lease
Plant and equipment
20% on reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
THE CLINIC (AYCLIFFE) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Fixed asset investments
Cryptographic and other non-monetary intangible assets are classified as fixed asset investments, other investments other than loans and initially measured at cost and subsequently measured at cost or valuation less accumulated amortisation and accumulated impairment losses.
Cryptocurrency and other non-monetary intangible assets whose fair value can be measured reliably are held under the revaluation model and are carried at revalued amount, being the fair value at the date of valuation less any subsequent accumulated impairment losses. The fair value is usually considered to be the market value.
Revaluation gains and losses are recognised in other comprehensive income and accumulated in equity, except to the extent that a revaluation gain reserves a revaluation loss previously recognised in profit or loss or a revaluation loss exceeds the accumulated revaluation gains recognised in equity; such gains and losses are recognised in profit or loss.
1.6
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
1.7
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
1.8
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.9
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
THE CLINIC (AYCLIFFE) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
1.10
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.11
Leases
As lessee
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
1.12
Government grants
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.
A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
0
0
THE CLINIC (AYCLIFFE) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 6 -
3
Tangible fixed assets
Leasehold improvements
Plant and equipment
Total
£
£
£
Cost
At 1 August 2024 and 31 July 2025
25,713
3,743
29,456
Depreciation and impairment
At 1 August 2024
1,891
2,557
4,448
Depreciation charged in the year
4,916
237
5,153
At 31 July 2025
6,807
2,794
9,601
Carrying amount
At 31 July 2025
18,906
949
19,855
At 31 July 2024
23,822
1,186
25,008
4
Fixed asset investments
2025
2024
£
£
Other investments other than loans
139,358
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 August 2024
139,358
Disposals
(139,358)
At 31 July 2025
-
Carrying amount
At 31 July 2025
-
At 31 July 2024
139,358
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
170,991
Other debtors
34,666
29,782
205,657
29,782
THE CLINIC (AYCLIFFE) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 7 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
5,274
5,145
Trade creditors
91,330
58,378
Amounts owed to group undertakings
70,000
83,618
Taxation and social security
7,424
4,810
Other creditors
79,255
65,333
253,283
217,284
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans
5,718
8
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
2
2
2
2
9
Operating lease commitments
As lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:
2025
2024
£
£
Total commitments
66,000
82,500
THE CLINIC (AYCLIFFE) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 8 -
10
Related party transactions
The company has taken advantage of exemption under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.
During the year the company continued to receive interest free loans from companies related by way of common director. These amounts are included within Creditors: Amounts falling due within one year, as there are no formal terms for repayment. As at the balance sheet date the total amount outstanding, included in other creditors, was £79,255 (2024: £65,333).
During the year the company maintained interest free loans to companies related by way of common director. As at the balance sheet date the total amount outstanding, included in other debtors, was £34,666 (2024: £29,782).
During the year the company was charged £25,100 (2024: £19,531) rent by a company related by way of common director. This was deemed by the director to be on market terms.
During the year the company was recharged wages/salaries borne by companies related by way of common director amounting to £13,922 (2024: £74,835), calculated on market terms.
11
Prior period adjustment
A prior period adjustment has been made to recognise the fair value gains on Cryptographic and other intangible assets in other comprehensive income as opposed to fair value through profit and loss.
The impact of the above on the 2024 financial statements is as follows:-
Changes to the balance sheet
As previously reported
Adjustment
As restated at 31 Jul 2024
£
£
£
Net assets
73
-
73
Capital and reserves
Revaluation reserve
-
77,280
77,280
Profit and loss reserves
71
(77,280)
(77,209)
Total equity
73
-
73
The prior period adjustments do not give rise to any effect upon total equity.